Clinical Trial: A Study of HDM2020 in Patients With Advanced Sq-NSCLC

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07638891) titled 'A Study of HDM2020 in Patients With Advanced Sq-NSCLC' on June 05.

Brief Summary: The goal of this clinical trial is to learn if the study drug can treat in advanced squamous non-small cell lung cancer(NSCLC) patients. The main questions it aims to answer are:

Is the drug safe and tolerable? Does the drug show antitumor activity? Participants will receive the study drug once(D1) or twice(D1.D8) every three weeks, and undergo imaging-based efficacy assessments every six weeks.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Squamous Non-small Cell Lung Cancer(NSCLC)

Intervention: DRUG: HDM2020 (FGFR2b-ADC)

Th...